Literature DB >> 21208761

Peripheral tissue oxygenation improves during ED treatment of acute heart failure.

Christopher J Hogan1, Kevin R Ward, Michael C Kontos, Leroy R Thacker, Roland Pittman.   

Abstract

OBJECTIVE: The objective of the study was to quantitatively characterize peripheral tissue microvascular oxygenation during emergency department (ED) treatment of acute heart failure (HF).
METHODS: This prospective, observational study enrolled acutely decompensated HF patients presenting to an urban ED and stable, asymptomatic HF patients evaluated in an outpatient cardiology clinic. Stable, pre-ED treatment, and post-ED treatment microvascular oxygen extraction ratios (OER(M)s) were calculated, defined as SaO(2) - StO(2)/0.8*SaO(2), where SaO(2) is pulse oximetry-derived arterial hemoglobin saturation and StO(2) is the tissue hemoglobin oxygen saturation measured with differential absorption spectroscopy. The OER(M) measurements were analyzed using repeated-measures analysis of variance. Pulse oximetry, patient demographics, HF etiology, serum B-type natriuretic peptide, and hemoglobin were measured along with a visual analogue scale to assess patient baseline characteristics and response to ED treatment (P < .05 was considered significant for all testing).
RESULTS: The OER(M) for the stable HF group (n = 45) was 0.65 (SE = 0.07). The pre- and posttreatment OER(M)s for the ED HF group (n = 46) were 0.92 (SE = 0.07) and 0.75 (SE = 0.06), respectively. Whereas the pretreatment ED OER(M) was higher than the stable patient OER(M) (P = .001), the posttreatment ED OER(M) was not significantly different from the stable patient measurement (P = .271).
CONCLUSIONS: Oxygen extraction in acute HF is significantly increased, but approaches values found in the stable HF population after ED treatment. The OER(M) may deserve closer examination as a possible goal-directed variable in the treatment of acute HF.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21208761      PMCID: PMC3223321          DOI: 10.1016/j.ajem.2010.10.019

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  18 in total

Review 1.  Heart failure in African Americans: unique etiology and pharmacologic treatment responses.

Authors:  Clyde W Yancy
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

2.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

3.  The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study.

Authors:  Mauro Di Bari; Claudia Pozzi; Maria Chiara Cavallini; Francesca Innocenti; Giorgio Baldereschi; Walter De Alfieri; Enrico Antonini; Riccardo Pini; Giulio Masotti; Niccolò Marchionni
Journal:  J Am Coll Cardiol       Date:  2004-10-19       Impact factor: 24.094

4.  The utility of microvascular perfusion assessment in heart failure: a pilot study.

Authors:  Christopher J Hogan; Michael L Hess; Kevin R Ward; Chris Gennings
Journal:  J Card Fail       Date:  2005-12       Impact factor: 5.712

5.  Rapid improvement of acute pulmonary edema with sublingual captopril.

Authors:  R J Hamilton; W A Carter; E J Gallagher
Journal:  Acad Emerg Med       Date:  1996-03       Impact factor: 3.451

Review 6.  Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine.

Authors:  Mihai Gheorghiade; Ferenc Follath; Piotr Ponikowski; Jeffrey H Barsuk; John E A Blair; John G Cleland; Kenneth Dickstein; Mark H Drazner; Gregg C Fonarow; Tiny Jaarsma; Guillaume Jondeau; Jose Lopez Sendon; Alexander Mebazaa; Marco Metra; Markku Nieminen; Peter S Pang; Petar Seferovic; Lynne W Stevenson; Dirk J van Veldhuisen; Faiez Zannad; Stefan D Anker; Andrew Rhodes; John J V McMurray; Gerasimos Filippatos
Journal:  Eur J Heart Fail       Date:  2010-03-30       Impact factor: 15.534

7.  Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure.

Authors:  Sean P Collins; Christopher J Lindsell; Alan B Storrow; William T Abraham
Journal:  Ann Emerg Med       Date:  2005-06-20       Impact factor: 5.721

8.  Near-infrared spectroscopy measurement of regional tissue oxyhemoglobin saturation during hemorrhagic shock.

Authors:  G J Beilman; K E Groehler; V Lazaron; J P Ortner
Journal:  Shock       Date:  1999-09       Impact factor: 3.454

Review 9.  Does this dyspneic patient in the emergency department have congestive heart failure?

Authors:  Charlie S Wang; J Mark FitzGerald; Michael Schulzer; Edwin Mak; Najib T Ayas
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

10.  Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department.

Authors:  D S Ander; M Jaggi; E Rivers; M Y Rady; T B Levine; A B Levine; J Masura; M Gryzbowski
Journal:  Am J Cardiol       Date:  1998-10-01       Impact factor: 2.778

View more
  3 in total

Review 1.  The actions of relaxin on the human cardiovascular system.

Authors:  Mohsin Sarwar; Xiao-Jun Du; Thomas B Dschietzig; Roger J Summers
Journal:  Br J Pharmacol       Date:  2016-07-11       Impact factor: 8.739

Review 2.  Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection.

Authors:  Javier Díez; Luis M Ruilope
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2015-11-26

3.  Evaluation of Skeletal Muscle Function and Effects of Early Rehabilitation during Acute Heart Failure: Rationale and Study Design.

Authors:  Kinga Węgrzynowska-Teodorczyk; Agnieszka Siennicka; Krystian Josiak; Robert Zymliński; Monika Kasztura; Waldemar Banasiak; Piotr Ponikowski; Marek Woźniewski
Journal:  Biomed Res Int       Date:  2018-03-12       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.